Neurocrine Biosciences, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 146.1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.85B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical develo...